Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...
making them visible on PET scans. Unlike conventional imaging, which provides only anatomical details, PSMA-PET offers functional imaging that reveals the cancer’s biological activity, which can ...
The Tennessee Department of Correction announced in a brief statement Friday it had "completed its revision of the lethal injection protocol, which will utilize the single drug pentobarbital." ...
Thus, a 10-min florbetapir F 18 scan 50 min after injection appears sufficient for evaluating the degree of amyloid pathology. Binary (β-amyloid–positive or β-amyloid–negative) visual interpretation ...